In article <3c88e3f5.977319471 at news.cis.dfn.de>,
Helgi Briem <helgi at decode.is> wrote:
>>Macs used to *own* the molecular biology market up until
>about 1995 and still have a sizeable, but rapidly decreasing
>proportion of it.
I think that's true, with the proviso that it was only ever true of the
the desktop machines being used in labs. Anyone doing larger scale work
would usually do it on a UNIX platform, because it's more automatable.
Now that MacOS X is here, and based around BSD UNIX, you can have the
best of both worlds with a Mac, in theory.
>The programming languages you see a lot of in biotech
>are Perl, C++ and Java, with some Python, Delphi, VB, and
>I suppose bits and pieces of everything else.
There's lots of perl glue code around, especially in large scale
automated pipelines (such as Ensembl). Most compute intensive stuff is
in C (not much C++, IME), and there is an increasing body of Java around
(look at the BioJava project, or things like Incyte's LifeSeq
Code re-use can be done in any language. Admittedly java promotes it
more than many languages, but it's possible to write nice re-useable
code in most languages.